BridgeBio Pharma : FDA Approves Heart Disease Drug 'acoramidis'
24/11 02:07
(RTTNews) - BridgeBio Pharma Inc. (BBIO) announced that the U.S. Food and Drug Administration approved Attruby or acoramidis, an orally-administered near-complete stabilizer of Transthyretin for the treatment of adults with Transthyretin amyloid cardiomyopathy (ATTR-CM) to reduce...